Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2011-10-18 / Int. Immunopharmacol. 2011 Dec;11(12):2200-7Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2011-09-28 / Clin. Dev. Immunol. 2011;2011:249281Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-10-13 / Int. J. Biol. Sci. 2010 Oct;6(7):639-48Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-08-22 / Cancer Biol. Ther. 2010 Aug;10(4):368-75Immunotherapy of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2010-06-01 / Expert Rev Gastroenterol Hepatol 2010 Jun;4(3):345-53Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines
/in Hepatocellular Carcinoma, International Publications /von 2010-03-30 / Hepatol. Res. 2010 May;40(5):505-13Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2010-03-10 / J. Cancer Res. Clin. Oncol. 2010 Nov;136(11):1745-54Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-02-28 / Korean J. Physiol. Pharmacol. 2010 Feb;14(1):11-4Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2009-11-20 / J. Gastroenterol. 2010 Apr;45(4):451-8IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de